Vargeese Chandra
See Remarks
Vargeese Chandra has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, Vargeese Chandra is listed as See Remarks at Wave Life Sciences Ltd. Inside the rolling window, Vargeese Chandra reported no open-market purchases and 1 open-market sale totaling $43K in WVE.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$43K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vargeese Chandra made?
Vargeese Chandra has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Vargeese Chandra trade?
Vargeese Chandra has filed SEC Form 4 disclosures for 1 company, including WVE.
When was Vargeese Chandra's most recent SEC Form 4 filing?
Vargeese Chandra's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is Vargeese Chandra's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Vargeese Chandra is listed as See Remarks.
What is Vargeese Chandra's total buy and sell value in the current window?
Inside the rolling retention window, Vargeese Chandra bought $0 and sold $43K based on SEC Form 4 filings.
What was Vargeese Chandra's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,228 WVE shares on 2026-02-09, worth $43K, per SEC Form 4 filings.